List of Sotylize drug patents

Sotylize is owned by Azurity.

Sotylize contains Sotalol Hydrochloride.

Sotylize has a total of 3 drug patents out of which 0 drug patents have expired.

Sotylize was authorised for market use on 22 October, 2014.

Sotylize is available in solution;oral dosage forms.

Sotylize can be used as sotylize is indicated for the maintenance of normal sinus rhythm [delay in time to recurrence of atrial fibrillation/atrial flutter (afib/afl)] in patients with symptomatic afib/afl who are currently in sinus rhythm, sotylize is indicated for the maintenance of normal sinus rhythm [delay in time to recurrence of atrial fibrillation/atrial flutter (afib/afl)] in patients with symptomatic afib/afl who are currently in sinus rhythm; indicated for the treatment of ventricular arrhythmias, such as sustained ventricular tachycardia, that in the judgement of the physician are life-threatening.

The generics of Sotylize are possible to be released after 31 August, 2035.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10206895 AZURITY Sotalol compositions and uses of the same
Apr, 2034

(11 years from now)

US11013703 AZURITY Sotalol compositions and uses of the same
Apr, 2034

(11 years from now)

US9724297 AZURITY Sotalol compositions and uses of the same
Aug, 2035

(12 years from now)

Drugs and Companies using SOTALOL HYDROCHLORIDE ingredient

Market Authorisation Date: 22 October, 2014

Treatment: Sotylize is indicated for the maintenance of normal sinus rhythm [delay in time to recurrence of atrial fibrillation/atrial flutter (afib/afl)] in patients with symptomatic afib/afl who are currently in sinus rhythm; Indicated for the treatment of ventricular arrhythmias, such as sustained ventricular tachycardia, that in the judgement of the physician are life-threatening

Dosage: SOLUTION;ORAL

More Information on Dosage

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in